Publications by authors named "Eric D Jacobsen"

Claim this Profile
I
Ipilimumab with and without nivolumab in patients with classic Hodgkin lymphoma with progression after PD-1 blockade.
Reid W Merryman, Justin Kline, Robert A Redd, Harrison Olszewski, Emma Welsh, Eric D Jacobsen

Blood Neoplasia· February 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early time to relapse as a survival prognosticator in mature T-cell/NK-cell lymphomas: results from the PETAL Consortium.
Mark N Sorial, Luis Malpica, Carlos Sergio Chiattone, Edith Julia, Emmannuel Bachy, Eric D Jacobsen

Blood· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Retrospective Study of Treatment and Outcomes in Synchronous Systemic and Central Nervous System Large B-cell Lymphoma.
J Erika Haydu, Robert A Redd, Matthew M Lei, Ephraim Hochberg, Jeffrey A Barnes, Eric D Jacobsen

Blood Adv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Refractory cutaneous Langerhans cell histiocytosis of the vulva treated with high-dose-rate surface applicator brachytherapy.
Stephanie Choi, Christopher J Fay, Eric D Jacobsen, Phillip M Devlin, Nicole R LeBoeuf

Leuk Lymphoma· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase-2 study of pembrolizumab in patients with biologically selected subtypes of relapsed/refractory aggressive lymphomas.
Mwanasha H Merrill, Robert A Redd, David C Fisher, Jeremy S Abramson, Jeffrey Barnes, Eric D Jacobsen

Leuk Lymphoma· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and outcomes of patients with double refractory and double exposed chronic lymphocytic leukemia.
James T Yoon, Yinglu Zhou, Mariia Mikhaleva, Daniel S Choi, Stacey M Fernandes, Eric D Jacobsen

Blood Adv· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case 18-2025: A 63-Year-Old Woman with Dyspnea on Exertion.
Malissa J Wood, Carola A Maraboto Gonzalez, Reece J Goiffon, Eric D Jacobsen, Bailey M Hutchison

N Engl J Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A real-world comparison of commercial-use axicabtagene ciloleucel and lisocabtagene maraleucel in large B-cell lymphoma.
Andrew Looka, David A Qualls, Daniel Matthews, Robert A Redd, Christopher Sakellis, Eric D Jacobsen

Blood Adv· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KLRG1 Cell Depletion as a Novel Therapeutic Strategy in Patients with Mature T-Cell Lymphoma Subtypes.
Bimarzhan Assatova, Robert Willim, Christopher Trevisani, Garrett Haskett, Khyati Maulik Kariya, Eric D Jacobsen

Clin Cancer Res· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of atorvastatin versus placebo on efficacy in patients with diffuse large B-cell lymphoma receiving R-CHOP.
Ronald Nemec, Marielle Scherrer-Crosbie, Jeremy S Abramson, Robert Redd, Hannah K Gilman, Eric D Jacobsen

Leuk Lymphoma· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multi-cohort phase 1b trial of rituximab in combination with immunotherapy doublets in relapsed/refractory follicular lymphoma.
Reid W Merryman, Robert A Redd, Arnold S Freedman, Inhye E Ahn, Jennifer R Brown, Eric D Jacobsen

Ann Hematol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 study of pembrolizumab after autologous stem cell transplantation in patients with T-cell non-Hodgkin lymphoma.
Mwanasha H Merrill, Parastoo B Dahi, Robert A Redd, Mikaela M McDonough, Yi-Bin Chen, Eric D Jacobsen

Blood· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atorvastatin for Anthracycline-Associated Cardiac Dysfunction: The STOP-CA Randomized Clinical Trial.
Tomas G Neilan, Thiago Quinaglia, Takeshi Onoue, Syed S Mahmood, Zsofia D Drobni, Eric D Jacobsen

JAMA· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1b study of ibrutinib in combination with obinutuzumab in patients with relapsed or refractory chronic lymphocytic leukemia.
Christine E Ryan, Danielle M Brander, Paul M Barr, Svitlana Tyekucheva, Liam R Hackett, Eric D Jacobsen

Leukemia· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poor outcome of CHOEP induction followed by gemcitabine/busulfan/melphalan high-dose therapy and stem cell rescue for patients with newly diagnosed peripheral T-cell lymphoma.
Eric D Jacobsen, Haesook T Kim, Erin Jeter, Caron Jacobson, David C Fisher

Bone Marrow Transplant· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cutaneous Langerhans cell histiocytosis in adults: A retrospective cohort study of adult patients presenting to a single academic cancer center between 2003 and 2017.
Ai-Tram N Bui, Cecilia Larocca, Anita Giobbie-Hurder, Eric D Jacobsen, Nicole R LeBoeuf

J Am Acad Dermatol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous EBV-specific T cell treatment results in sustained responses in patients with advanced extranodal NK/T lymphoma: results of a multicenter study.
Won Seog Kim, Yasuhiro Oki, Seok Jin Kim, Sang Eun Yoon, Kirit M Ardeshna, Eric D Jacobsen

Ann Hematol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-grade heart block associated with ibrutinib therapy.
Alexander R Vartanov, Benjamin L Lampson, Eric D Jacobsen, Edwin P Alyea, Javid J Moslehi

HeartRhythm Case Rep· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting constitutively active STAT3 in chronic lymphocytic leukemia: A clinical trial of the STAT3 inhibitor pyrimethamine with pharmacodynamic analyses.
Jennifer R Brown, Sarah R Walker, Lisa N Heppler, Svitlana Tyekucheva, Erik A Nelson, Eric D Jacobsen

Am J Hematol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spatial signatures identify immune escape via PD-1 as a defining feature of T-cell/histiocyte-rich large B-cell lymphoma.
Gabriel K Griffin, Jason L Weirather, Margaretha G M Roemer, Mikel Lipschitz, Alyssa Kelley, Eric D Jacobsen

Blood· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cutaneous Langerhans Cell Histiocytosis Responsive to Topical Nitrogen Mustard.
Ai-Tram N Bui, Ashleigh Eberly Puleo, Alvaro Laga Canales, Eric D Jacobsen, Nicole R LeBoeuf

J Drugs Dermatol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era.
Gaurav Goyal, Mark L Heaney, Matthew Collin, Fleur Cohen-Aubart, Augusto Vaglio, Eric D Jacobsen

Blood· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-1 blockade for diffuse large B-cell lymphoma after autologous stem cell transplantation.
Matthew J Frigault, Philippe Armand, Robert A Redd, Erin Jeter, Reid W Merryman, Eric D Jacobsen

Blood Adv· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia.
Philipp B Staber, Marco Herling, Mar Bellido, Eric D Jacobsen, Matthew S Davids

Blood· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral T-Cell Lymphoma: Moving Toward Targeted Therapies.
Samuel Y Ng, Eric D Jacobsen

Hematol Oncol Clin North Am· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis